105 related articles for article (PubMed ID: 25191960)
1. The effect of sibutramine, a serotonin-norepinephrine reuptake inhibitor, on platelets and fibrin networks of male Sprague-Dawley rats: a descriptive study.
van der Schoor C; Oberholzer HM; Bester MJ; van Rooy MJ
Ultrastruct Pathol; 2014 Dec; 38(6):399-405. PubMed ID: 25191960
[TBL] [Abstract][Full Text] [Related]
2. The effect of sibutramine on platelet morphology of Spraque-Dawley rats fed a high energy diet.
Oberholzer HM; Van Der Schoor C; Pretorius E
Microsc Res Tech; 2013 Jun; 76(6):653-7. PubMed ID: 23576325
[TBL] [Abstract][Full Text] [Related]
3. Sibutramine, a serotonin-norepinephrine reuptake inhibitor, causes fibrosis in rats.
Oberholzer HM; van der Schoor C; Bester MJ
Environ Toxicol Pharmacol; 2015 Jul; 40(1):71-6. PubMed ID: 26070021
[TBL] [Abstract][Full Text] [Related]
4. Comparing techniques: the use of recalcified plasma in comparison with citrated plasma alone and in combination with thrombin in ultrastructural studies.
Pretorius E; Oberholzer HM; van der Spuy WJ; Franz RC
Hematology; 2011 Nov; 16(6):337-40. PubMed ID: 22183067
[TBL] [Abstract][Full Text] [Related]
5. Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes.
Pretorius E; Oberholzer HM; van der Spuy WJ; Swanepoel AC; Soma P
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):463-7. PubMed ID: 21467917
[TBL] [Abstract][Full Text] [Related]
6. Comparative ultrastructural analyses of platelets and fibrin networks using the murine model of asthma.
Pretorius E; Ekpo OE; Smit E
Exp Toxicol Pathol; 2007 Oct; 59(2):105-14. PubMed ID: 17600694
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural changes to rabbit fibrin and platelets due to aspartame.
Pretorius E; Humphries P
Ultrastruct Pathol; 2007; 31(2):77-83. PubMed ID: 17613990
[TBL] [Abstract][Full Text] [Related]
8. Rats on a high-energy diet showing no weight gain present with ultrastructural changes associated with liver fibrosis.
Oberholzer HM; Bester MJ; van der Schoor C
Ultrastruct Pathol; 2013 Aug; 37(4):267-72. PubMed ID: 23672266
[TBL] [Abstract][Full Text] [Related]
9. Comparative ultrastructural analyses of mouse, rabbit, and human platelets and fibrin networks.
Pretorius E; Humphries P; Ekpo OE; Smit E; van der Merwe CF
Microsc Res Tech; 2007 Sep; 70(9):823-7. PubMed ID: 17576129
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructure of platelets and fibrin networks of asthmatic mice exposed to selenium and Withania somnifera.
Pretorius E; Oberholzer HM; Vieira WA; Smit E
Anat Sci Int; 2009 Sep; 84(3):210-7. PubMed ID: 19214657
[TBL] [Abstract][Full Text] [Related]
11. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
Kumar R; Béguin S; Hemker HC
Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
[TBL] [Abstract][Full Text] [Related]
12. 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
Thomas GH; Babbs AJ; Chatfield RE; Krülle TM; Widdowson PS; Provost D; McCormack JG
Obesity (Silver Spring); 2009 Mar; 17(3):467-73. PubMed ID: 19219064
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural comparison of the morphology of three different platelet and fibrin fiber preparations.
Pretorius E; Briedenhann S; Marx J; Smit E; Van Der Merwe C; Pieters M; Franz C
Anat Rec (Hoboken); 2007 Feb; 290(2):188-98. PubMed ID: 17441211
[TBL] [Abstract][Full Text] [Related]
14. Investigating the effect of a platelet additive solution on apheresis platelet and fibrin network ultrastructure.
Pretorius E; Crookes R; Oberholzer HM; van der Spuy WJ
Transfus Apher Sci; 2010 Dec; 43(3):347-351. PubMed ID: 21036668
[TBL] [Abstract][Full Text] [Related]
15. Macrothrombocytopenia: investigating the ultrastructure of platelets and fibrin networks using scanning and transmission electron microscopy.
Pretorius E; Oberholzer HM; van der Spuy WJ; Meiring JH
Ultrastruct Pathol; 2009 Oct; 33(5):216-21. PubMed ID: 19895294
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural characteristics of fibrin clots from canine and feline platelet concentrates activated with calcium gluconate or calcium gluconate plus batroxobin.
Silva RF; Carmona JU; Rezende CM
BMC Vet Res; 2013 Apr; 9():77. PubMed ID: 23587176
[TBL] [Abstract][Full Text] [Related]
17. Proteome changes in rat plasma in response to sibutramine.
Choi JW; Joo JI; Kim DH; Wang X; Oh TS; Choi DK; Yun JW
Proteomics; 2011 Apr; 11(7):1300-12. PubMed ID: 21337517
[TBL] [Abstract][Full Text] [Related]
18. Acute cardiovascular effects of sibutramine in conscious rats.
Woolard J; Bennett T; Dunn WR; Heal DJ; Aspley S; Gardiner SM
J Pharmacol Exp Ther; 2004 Mar; 308(3):1102-10. PubMed ID: 14634034
[TBL] [Abstract][Full Text] [Related]
19. Structural changes in the fibrin network of a pretoria family with dysfibrinogenemia: a scanning electron microscopical study.
Pretorius E; Briedenhann S; Marx J; Franz RC
Ultrastruct Pathol; 2006; 30(3):167-76. PubMed ID: 16825118
[TBL] [Abstract][Full Text] [Related]
20. Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography study.
van Rooy MJ; Duim W; Ehlers R; Buys AV; Pretorius E
Cardiovasc Diabetol; 2015 Jul; 14():86. PubMed ID: 26140921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
